Age Related Macular Degeneration and Visual Disability
Open accessThe DOI matches its Crossref record.
Abstract
Age-related macular degeneration (AMD) is the leading cause of central blindness or low vision among the elderly in industrialized countries. AMD is caused by a combination of genetic and environmental factors. Among modifiable environmental risk factors, cigarette smoking has been associated with both the dry and wet forms of AMD and may increase the likelihood of worsening pre-existing AMD. Despite advances, the treatment of AMD has limitations and affected patients are often referred for low vision rehabilitation to help them cope with their remaining eyesight. The characteristic visual impairment for both forms of AMD is loss of central vision (central scotoma). This loss results in severe difficulties with reading that may be only partly compensated by magnifying glasses or screen-projection devices. The loss of central vision associated with the disease has a profound impact on patient quality of life. With progressive central visual loss, patients lose their ability to perform the more complex activities of daily living. Common vision aids include low vision filters, magnifiers, telescopes and electronic aids. Low vision rehabilitation (LVR) is a new subspecialty emerging from the traditional fields of ophthalmology, optometry, occupational therapy, and sociology, with an ever-increasing impact on the usual concepts of research, education, and services for visually impaired patients. Relatively few ophthalmologists practise LVR and fewer still routinely use prismatic image relocation (IR) in AMD patients. IR is a method of stabilizing oculomotor functions with the purpose of promoting better function of preferred retinal loci (PRLs). The aim of vision rehabilitation therapy consists in the achievement of techniques designed to improve PRL usage. The use of PRLs to compensate for diseased foveae has offered hope to these patients in regaining some function. However, in a recently published meta-analysis, prism spectacles were found to be unlikely to be of substantial benefit in people with age-related macular degeneration. Prescription filters are one of the most beneficial visual aids for people with macular degeneration. In principle, one aims both at reducing short-wavelength light to reduce glare and at identifying light with specific wavelengths (colours) preferred by the patient for viewing. In both instances, such interventions result in apparent improved contrast sensitivity and better visual acuity. Although specific tests are performed to determine the best colour, tint, lens material, and type of frame for the patients need, no scientific protocol has been developed so far to assist in prescribing tinted or selective transmission lenses. Magnifying optical lenses are available in a wide range of dioptric powers and are made from materials that correct for weight (plastic), thickness (high index), spherical aberrations (aspherical), and variable light intensities (photochromatic). These lenses can be used as loose lenses, mounted on optical frames, or used with a wide variety of attachments. As the dioptric power of plus lenses increases, the viewing distance of the target decreases, hence their usefulness mainly for tasks requiring near resolution acuity, like reading. Magnification can also be achieved with the use of telescopic devices that are built of two or more plus and (or) minus (minifying) optical lenses. Normal resolution acuity levels can be achieved with these devices for all viewing distances. Therefore, all telescopic devices are useful only for stationary patient tasks that do not require mobility and orientation. Electronic magnification has the great advantage over plus lenses of producing an acuity reserve enabling reading skills for almost all levels of visual acuity. The additional benefit provided is preservation of binocularity, even at high levels of visual disparity between the two eyes. Vision rehabilitation can help patients to maximize their remaining vision and adapt to activities of daily living. The support of the patients social network is critical to patients well-being as patients adjust to being partially sighted. Keywords: Age related macular degeneration, visual disability, magnifying glasses, telescopes and electronic aids, prescription filters, epidemiology, risk factors, blindness, low vision, central scotoma, Low vision rehabilitation, prismatic image relocation (IR), preferred retinal loci (PRLs), Magnifying optical lenses, dioptric powers, photochromatic, binocularity, visual disparity, macula, retinal pigment epithelium (RPE), photoreceptors, Hypoxia, retinal edema, choriocapillaris, metamorphopsia, hemorrhage, exudation, neurodegeneration, angiogenic factors, angiogenesis, tumour necrosis factor-alpha, standard refractive correction, glaucoma, cataract, Estrogen, menopause, ovariectomy, hypertension, hyperlipidemia, coalesce, blind spots, intraretinal hemorrhages, funduscopic examination, optical coherence tomography (OCT), The Amsler Grid
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Still being checked.
Cited by
Carazo, A., Macáková, K., Matoušová, K., Krčmová, L. K., Protti, M., & Mladěnka, P. (2021) · Nutrients · doi:10.3390/nu13051703 · Cited by 461
Hammond, B. R., Fletcher, L. M., & Elliott, J. G. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10411 · Cited by 86
Lyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45
Macular degeneration and occupational risk factors: a systematic review
Modenese, A., & Gobba, F. (2018) · International Archives of Occupational and Environmental Health · doi:10.1007/s00420-018-1355-y · Cited by 58
Complement Regulatory Protein CD46 Protects against Choroidal Neovascularization in Mice
Lyzogubov, V., Wu, X., Jha, P., Tytarenko, R., Triebwasser, M., Kolar, G., Bertram, P., Bora, P. S., Atkinson, J. P., & Bora, N. S. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.06.001 · Cited by 41
“Thus, AMD profoundly affects the quality of life, creating a serious social and public health problem.(3,4) Two major clinical phenotypes of AMD are recognized: nonexudative (dry type) and exudative (wet type).”
BackgroundNguyen, Q. D., Agarwal, A. K., Rhoades, W. R., Hanout, M., Soliman, M. K., Sarwar, S., Sadiq, M. A., Sepah, Y. J., & Diana, V. (2015) · Clinical ophthalmology · doi:10.2147/opth.s74959 · Cited by 50
Shahidatul-Adha, M., Zunaina, E., & Aini-Amalina, M. N. (2022) · Scientific Reports · doi:10.1038/s41598-022-08492-7 · Cited by 39
Rap1 GTPase Activation and Barrier Enhancement in RPE Inhibits Choroidal Neovascularization In Vivo
Wittchen, E. S., Nishimura, E., McCloskey, M., Wang, H., Quilliam, L. A., Chrzanowska‐Wodnicka, M., & Hartnett, M. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073070 · Cited by 34
Effects of Age-Related Macular Degeneration on Postural Sway
Chatard, H., Tépenier, L., Jankowski, O., Aussems, A., Allieta, A., Beydoun, T., Salah, S. B., & Bucci, M. P. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00158 · Cited by 32
The Visual Effects of Intraocular Colored Filters
Hammond, B. R. (2012) · Scientifica · doi:10.6064/2012/424965 · Cited by 23
Rai, B. B., Essex, R. W., Sabeti, F., Maddess, T., Rohan, E. M. F., van Kleef, J., & Carle, C. F. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.14.24 · Cited by 18
Anti-VEGF dosing regimen for neovascular age-related macular degeneration treatment
Fayzrakhmanov, R. R. (2018) · Russian Annals of Ophthalmology · doi:10.17116/oftalma2018134061107 · Cited by 17
Tissue engineering in age-related macular degeneration: a mini-review
Wu, A., Lu, R., & Lee, E. (2022) · Journal of Biological Engineering · doi:10.1186/s13036-022-00291-y · Cited by 19
Rai, B. B., Morley, M. G., Bernstein, P. S., & Maddess, T. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02520-w · Cited by 13
Home Low Vision Ocular Rehabilitation Telehealth Expansion Due to COVID-19 Pandemic
Ihrig, C. (2021) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2021.0264 · Cited by 13
Sun, C., Huang, T., Fu, T., Lee, C., Chen, B., & Chen, F. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037028 · Cited by 11
Is it time for an evidence based uniform for doctors?
Clement, R. (2012) · BMJ · doi:10.1136/bmj.e8286 · Cited by 9
Nowak, M. S., Jurowski, P., Grzybowski, A. E., Goś, R., Pastuszka, M., Kapica, A., & Śmigielski, J. (2012) · Medical Science Monitor · doi:10.12659/msm.882907 · Cited by 9
Rinaldi, M., Pezone, A., Quadrini, G. I., Abbadessa, G., Laezza, M. P., Passaro, M. L., Porcellini, A., & Costagliola, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1371745 · Cited by 11
Self-citationCaballe-Fontanet, D., Alvarez-Peregrina, C. C., Busquet-Duran, N., Pedemonte-Sarrias, E., & Sánchez‐Tena, M. Á. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186751 · Cited by 9
Role of Adiponectin Peptide I (APNp1) in Age-Related Macular Degeneration
Logan, C., Lyzogubov, V. V., Bora, N. S., & Bora, P. S. (2022) · Biomolecules · doi:10.3390/biom12091232 · Cited by 9
Hyttinen, J. M. T., Niittykoski, M., & Kaarniranta, K. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102796 · Cited by 11
Pandey, G., Kolipaka, T., Yadav, D., Methri, S. M., Singh, A. K., Natesan, S., & Srivastava, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126781 · Cited by 8
Moshtaghion, S. M., Locri, F., Reyes, Á. P., Plastino, F., Kvanta, A., Morillo-Sánchez, M. J., Rodríguez-de-la-Rúa-Franch, E., Gutiérrez‐Sánchez, E., Montero-Sánchez, A., Lucena-Padros, H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083855 · Cited by 8
Raphanel, M., Shaughness, G., Seiple, W., & Arleo, A. (2018) · Journal of Aging Science · doi:10.4172/2329-8847.1000194 · Cited by 10
Farzaneh, A., Riazi, A., Falavarjani, K. G., Doostdar, A., Kamali, M., Sedaghat, A., & Khabazkhoob, M. (2021) · Journal of Current Ophthalmology · doi:10.4103/joco.joco_192_20 · Cited by 7
Subramanian, A., Han, J. E., Braithwaite, T., Thayakaran, R., Zemedikun, D. T., Gokhale, K. M., Lee, W. H., Coker, J., Keane, P. A., Denniston, A. K., et al. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15366 · Cited by 8
Jo, D. H., Lee, J. H., Jun, H., Kim, J. H., Wen, Q., Hoang, M. H., Yu, Y., Kim, J. H., Kim, J. H., & Lee, S. (2015) · Genetics and Molecular Research · doi:10.4238/2015.march.13.14 · Cited by 5
Eschweiler, G. W., & Wanner, L. (2018) · Cited by 11
Aşıkgarip, N., Temel, E., & Örnek, K. (2021) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2021.102383 · Cited by 5
The Mind Cannot Go Blind: Effects of Central Vision Loss on Judging One's Crossing Time
Graber, M. S., & Hassan, S. E. (2020) · Optometry and Vision Science · doi:10.1097/opx.0000000000001525 · Cited by 4
Dussán, G. A. (2017) · Ciencia y Tecnología para la Salud Visual y Ocular · doi:10.19052/sv.3999 · Cited by 8
Jezani, S. N., & Bastion, M.-L. C. (2025) · Medicine · doi:10.1097/md.0000000000042666 · Cited by 4
Actualización en el manejo de la degeneración macular asociada a la edad
Lozano, I. G., García, S. L., & de Juán, I. E. (2012) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2011.11.011 · Cited by 11
Vega, L. L., Alcoceba-Herrero, I., Martín-Gutiérrez, A., Medina, J. H., Cruz, N. M., Arenillas, J. F., & Martín, M. B. C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96817 · Cited by 2
Recent Advances and New Perspectives in Managing Macular Degeneration
Davey, P. G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.91530 · Cited by 2
New Discoveries in Retinal Cell Degeneration and Retinal Diseases
Bora, P. S. (2023) · Biomolecules · doi:10.3390/biom13071121 · Cited by 2
Jančo, L., Stefanickova, J., Bušányová, B., Sustykevicova, Z., Pavlovicova, G., Kusenda, P., Branikova, L., Mattova, J., Sedláková, A., Javorska, L., et al. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00140-6 · Cited by 1
Nagaratnam, N., Nagaratnam, K., & Cheuk, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-33434-9_95 · Cited by 1
Baguer, R. H., Casado, I. T., García, M. R. C., & Vázquez, B. C. (2012)
da Silva, J. M. C. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/cth4-h086 · Cited by 6
Máster en Rehabilitación Visual
Medicina, F. D. (2015)
Nagaratnam, N., Nagaratnam, K., & Cheuk, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-32700-6_95-1
Assessment of visual acuity improvement in patients with AMD referred to the low vision department
Moraes, G., Marcos, A. A. A., Barros, G. D. S. S., & Filho, H. A. D. C. (2018) · Revista Brasileira de Oftalmologia · doi:10.5935/0034-7280.20180016
ASMENŲ, TURINČIŲ REGĖJIMO SUTRIKIMŲ, REABILITACIJOS GALIMYBĖS
Žilinskaitė, U., & Varžaitytė, L. (2019) · Sveikatos mokslai · doi:10.5200/sm-hs.2019.026
Estudo preliminar do acesso as bulas de medicamentos destinadas a portadores de deficiência visual
Leite, B., & Guanaes, L. D. (2022) · Cadernos da Escola de Saúde · doi:10.25192/1984-7041.v21i26354
Cost analysis of aflibercept 8 mg versus other anti-VEGF agents
Shadrichev, F. E., & Strunina, Y. V. (2026) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202614202140
Spontaneous whole retinal degeneration in aged Beclin1 heterozygous mice
Biagioni, F., Forte, M., Nonno, F. D., Busceti, C. L., Pinelli, R., Bumah, V. V., Ferrucci, M., Lazzeri, G., Sciarretta, S., Frati, G., et al. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03166-4
Insights into age-related macular degeneration
Lankry, P., Loewenstein, A., & Trivizki, O. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-22212-2.00020-3
Moshtaghion, S. M., Shayan, M., Ramakrishnan, S., Ham, A., Gharehkoshan, A. S., Morley, M. G., Zebardast, N., Diaz-Corrales, F. J. J., Rodríguez-de-la-Rúa-Franch, E., Husain, D., et al. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1912337
Lee, A., Park, S., Strang, J., Braun, T., Yang, H., Naef, R., & Jung, H. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.07.067
Metadata
- Authors
- B. Christoforidis, J., Tecce, N., Dell'Omo, R., Mastropasqua, R., Verolino, M., & Costagliola, C.
- Affiliations
- University of Molise (IT)
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-02-01
- Volume
- 12
- Issue
- 2
- Pages
- 221-233
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2027191356
- Cited by
- 52
- References
- 0
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 6 · 2021: 7 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 2 · 2012: 6
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- Current Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi del Molise (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Aging, Health, and Disability
- Keywords
- age-related macular degeneration, low vision rehabilitation, visual impairment, central scotoma, preferred retinal locus, tinted lenses, magnifying lenses, visual aids, activities of daily living, quality of life, smoking as risk factor, central vision loss, contrast sensitivity, glare reduction, reading difficulties
- MeSH terms
- Activities of Daily Living, Blindness, Humans, Macular Degeneration, Vision, Low, Persons with Visual Disabilities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.